Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The new face mask with Eflornithine can potentially reduce facial hair growth and moisturize skin.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Vitamin D is crucial for skin health and managing skin diseases.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

A woman with Cushing's syndrome improved after surgery to remove an adrenal tumor.

New treatments for male hypogonadism are effective and should be personalized.